Conclusion This investigation addressed the inhibitory effects and underlying mechanisms of TSA, a pan HDAC inhibitor, in DLBCL cells. TSA suppressed the growth of all three DLBCL cell lines by enhanced G0/G1 or G2/M arrest and possible apoptosis. Expression levels of HDACs varied in the three cell lines, with DoHH2 cells things exhibiting the highest expression of all six isoforms of HDAC1 6. The expression levels of HDACs may be associated with TSA sensitivity. Upregulated acetylation of histone H3, tubulin and p53 and dephosphorylation of pAkt with alter ations of its main downstream effectors suggested that inhibition of Akt and activation of the p53 pathway may be the main mo lecular events involved in the TSA inhibitory effects. Our results have offered evidence supporting the development of HDAC inhibitors to combat DLBCL more efficiently.

Studies in more DLBCL cell lines treated with different HDACi are needed to provide more substantial evidence and clarify the roles and mechanisms of HDACi on DLBCL to enhance their clinical applicability. Methods Cell lines and culture conditions Three human DLBCL cell lines, LY1, LY8 and DoHH2, were used in this study. LY1 and LY8 cells were kindly pro vided by Dr B. Hilda Ye and grown in IMDM medium supplemented with 10% FBS. DoHH2 cells were a gift from Prof. Mingzhi Zhang and cultured in RPMI1640 containing 10% FBS. Cells were grown and maintained at 37 C in a 5% CO2 humidified atmosphere. Reagents and treatments TSA was dissolved in DMSO as a 5 uM stock solution, aliquoted and stored at ?20 C.

Control cells were treated with DMSO and analyzed in parallel in each experiment. DoHH2, LY1 and LY8 cells were treated with TSA at con centrations ranging from 5 nM to 1000 nM for 24 72 h. Cell viability was determined by the cell counting kit 8 and fifty percent growth inhibition of a 48 h TSA exposure in each cell line was obtained from Probit Regression using SPSS16. 0. From these results, we selected the following treatment levels for subsequent experiments 50 nM TSA for DoHH2 cells, and 300 nM TSA for LY1 and LY8 cells. Cell proliferation assay Cell proliferation was assessed using the CCK 8 assay according to the manufacturers instructions. Cells were seeded into a 96 well plate and cultured in RPMI1640 supplemented with 10% FBS containing concentrations of TSA ranging from 0 to 1000 nM.

The plate was incubated in Brefeldin_A a humidified incu bator for 24 72 h. Four hours before measuring the absorbance, 10 ul of the CCK 8 solution was added into each well. Cell viability was obtained as the percentage of viable cells relative to untreated cells under the absorbance at 450 nm in a microplate reader. Two control wells without cells were prepared and average absorbance of the control wells was subtracted from that of the corre sponding sample wells. Each experiment was performed in triplicate. Cell cycle analysis Cells incubated with or without TSA were fixed gently in absolute ethanol overnight at ?20 C.